How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

27,749 results for

Topical Corticosteroid

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Saline irrigation and corticosteroid spray are effective first choice treatments for chronic sinusitis

SMD indicates improvement). Topical corticosteroid therapy improved overall symptom scores (SMD, -0.46 [95% CI, -0.65 to -0.27]; a negative SMD indicates improvement), improved polyp scores (SMD, -0.73 [95% CI, -1.0 to -0.46]; a negative SMD indicates improvement), and reduced polyp recurrence after surgery (relative risk, 0.59 [95% CI, 0.45 to 0.79]). Systemic corticosteroids and oral doxycycline (both for 3 weeks) reduced polyp size compared with placebo for 3 months after treatment (P < .001 (...) ). Leukotriene antagonists improved nasal symptoms compared with placebo in patients with nasal polyps (P < .01). Macrolide antibiotic for 3 months was associated with improved QOL at a single time point (24 weeks after therapy) compared with placebo for patients without polyps (SMD, -0.43 [95% CI, -0.82 to -0.05]). CONCLUSIONS AND RELEVANCE: Evidence supports daily high-volume saline irrigation with topical corticosteroid therapy as a first-line therapy for chronic sinusitis. A short course of systemic

2018 NIHR Dissemination Centre

142. Prescribing for rheumatological conditions in pregnancy and breastfeeding - Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids.

Prescribing for rheumatological conditions in pregnancy and breastfeeding - Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs (...) and corticosteroids | Rheumatology | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close mobile search navigation Article navigation September 2016 Article Contents Article Navigation BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids Julia Flint 1 Centre for Rheumatology Research, UCL Division of Medicine

Full Text available with Trip Pro

2016 British Society for Rheumatology

143. Corticosteroid treatment of duchenne muscular dystrophy

Corticosteroid treatment of duchenne muscular dystrophy Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy | Neurology Advertisement Search for this keyword Main menu User menu Search Search for this keyword The most widely read and highly cited peer-reviewed neurology journal Share February 02, 2016 ; 86 (5) Special Article Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy Report of the Guideline Development (...) .), Loma Linda University Medical Center, CA; and Departments of Pediatric and Neurology/Neurosurgery (M.O.), McGill University, Montréal, Canada. Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy David Gloss , Richard T. Moxley , Stephen Ashwal , Maryam Oskoui Neurology Feb 2016, 86 (5) 465-472; DOI: 10.1212/WNL.0000000000002337 Citation Manager Formats Make Comment See Comments Downloads 5504 Share Abstract Objective: To update the 2005 American Academy

2016 American Academy of Neurology

144. Topical steroids better than vitamin D for treating scalp psoriasis

. In extreme cases it can cause hair loss, although this is usually only temporary. Topical treatments (creams and ointments for the skin) such as corticosteroids (steroids) and vitamin D are usually the first treatments tried, but applying them to the scalp is difficult because of hair on the head. It is also not clear which works best. This study aimed to help doctors and patients decide which of the wide variety of topical treatments available work best, and the type and frequency of any side effects (...) treatments were made: topical steroid alone versus vitamin D alone; combination therapy (corticosteroid and vitamin D therapy) versus steroid alone; combination therapy versus vitamin D alone. Trials concerning these three outcomes were rated as moderate or high quality, most lasted less than six months, and around half were carried out or sponsored by the manufacturer of the study medication. Sponsor involvement can bias results – in this case they can be more likely to find differences where

2019 NIHR Dissemination Centre

145. Diaper Dermatitis, Irritant and Candidal - Guidelines for Prescribing Topical Antifungals and Hydrocortisone

Diaper Dermatitis, Irritant and Candidal - Guidelines for Prescribing Topical Antifungals and Hydrocortisone Diaper Dermatitis, Irritant and Candidal - Guidelines for Prescribing Topical Antifungals and Hydrocortisone - medSask Home - College of Pharmacy and Nutrition - University of Saskatchewan Toggle Menu Search the U of S Search Diaper Dermatitis, Irritant and Candidal - Guidelines for Prescribing Topical Antifungals and Hydrocortisone A rash occurring under the covered area of a diaper (...) to confirm diagnosis and symptoms / history suggestive of other conditions (See Differential Diagnosis ) which require further investigation and supervised therapy. Mild diaper dermatitis usually responds well to non-pharmaracological measures and regular use of topical barrier products. Topical hydrocortisone and antifungal products should be reserved for symptoms which are causing infant discomfort. Non-pharmacological measures Frequent diaper changes. Change the diaper up to every 2 hours, or any time

2017 medSask

146. Superficial Bacterial Skin Infections - Guidelines for Prescribing Topical Antibiotics for impetigo and folliculitis

peels and becomes inflamed resembling a burn. This most often affects infants and children under 5 years old. Burns Folliculitis and Furuncles (Boils): Irritant folliculitis: caused by shaving, plucking, waxing, etc. Advise patient to stop hair removal procedure for three months after symptoms of folliculitis resolve. (Topical antibiotics are not effective.) Contact folliculitis: may be caused by petroleum jelly, lanolin, moisturizers, coal tar and overuse of topical corticosteroids. which may (...) Superficial Bacterial Skin Infections - Guidelines for Prescribing Topical Antibiotics for impetigo and folliculitis Superficial Bacterial Skin Infections - Guidelines for Prescribing Topical Antibiotics for impetigo and folliculitis - medSask Home - College of Pharmacy and Nutrition - University of Saskatchewan Toggle Menu Search the U of S Search Superficial Bacterial Skin Infections - Guidelines for Prescribing Topical Antibiotics for impetigo and folliculitis The skin has an effective

2017 medSask

147. Treating Atopic Dermatitis: Wet Wraps With Corticosteroids Versus Wet Wrap Therapy Without Corticosteroids

treatment, is usually reserved for children and adults with severe atopic dermatitis. The mainstay of treatment for atopic dermatitis has been emollients and topical corticosteroids. However, corticosteroids, especially when used long-term can have side effects that are a cause for concern. What additional benefits can be seen when adding a topical steroid to wet wrap therapy versus using emollient with wet wrap therapy alone? Methods: An exhaustive search of available medical literature was conducted (...) reduction in atopic dermatitis in the group treated with topical corticosteroid and wet wrap therapy vs. treatment with emollients and wet wrap therapy alone. An observational study with 8 participants observed that after one week the emollient only wet wrap therapy group showed only minor improvement while the steroid wet wrap group showed major improvement. Conclusion: Wet wrap therapy is effective in treating refractory atopic dermatitis and in combination with diluted fluticasone proprionate 0.05

2015 Pacific University EBM Capstone Project

148. Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis: Post Hoc Analyses from the VISUAL-1 and VISUAL-2 Trials. (PubMed)

was estimated controlling for time-dependent corticosteroid dose, age, sex, prior oral corticosteroid dose, prior topical corticosteroid use, and concomitant immunosuppressive drug use. Only patients randomized to placebo were considered.The primary outcome measure was the frequency of AEs.The incidence rates of corticosteroid-related AEs among placebo patients during the prednisone treatment period in VISUAL-1 was statistically higher than after discontinuation (454.2 per 100 patient-years [PY] vs. 36.1 (...) Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis: Post Hoc Analyses from the VISUAL-1 and VISUAL-2 Trials. Chronic use of corticosteroids for the treatment of uveitis has been linked with drug-associated toxicity and adverse events (AEs). This study examines the association between corticosteroid dosage and incidence rates of corticosteroid-related AEs.A post hoc analysis of the VISUAL-1 and VISUAL-2

Full Text available with Trip Pro

2017 Ophthalmology

149. Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection

(Participant) Primary Purpose: Treatment Official Title: Randomized Prospective Study of Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Steroid Injection Actual Study Start Date : September 14, 2017 Estimated Primary Completion Date : September 2020 Estimated Study Completion Date : September 2020 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental (...) Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2017 Clinical Trials

150. The Efficacy of Topical Sesame Oil Versus Topical Triamcinolone on Oral Lichen Planus and Salivary Level of Oxidative Stress Biomarker [MDA]

to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03738176 Recruitment Status : Not yet recruiting First Posted : November 12, 2018 Last Update Posted : November 12, 2018 See Sponsor: Mona Taha Mohammed MD Information provided by (Responsible Party): Mona Taha Mohammed MD, Cairo University Study Details Study Description Go to Brief Summary: use seseme oil and corticosteroid topically for two groups Condition or disease Intervention/treatment (...) Phase Oral Lichen Planus Drug: Sesame Oil Drug: triamcinolone in orabase Early Phase 1 Detailed Description: The enrolled patients will be divided randomly into two groups. Test group will receive topical sesame oil (3 times /day after eating) for a month. Control group will receive topical corticosteroid (3 times /day after eating) for a month. Assessment of the appearance score and severity of pain as well as the clinical parameter outcome will be done at baseline and at the end of two and four

2018 Clinical Trials

151. Psoriasis and Atopic Dermatitis "Resistant" to Topical Treatment Responds Rapidly to Topical Desoximetasone Spray. (PubMed)

Psoriasis and Atopic Dermatitis "Resistant" to Topical Treatment Responds Rapidly to Topical Desoximetasone Spray. Topical corticosteroids (TS) are a treatment for atopic dermatitis (AD) and psoriasis (Ps). We assessed whether use of a TS under conditions designed to enhance adherence would be effective in patients who "failed" TS in the outpatient setting.Individuals with treatment-resistant Ps or AD were recruited (AD, n = 12; Ps, n = 12). Six participants were randomized to each of 2 groups

2018 Journal of cutaneous medicine and surgery

152. Corticosteroids and Prophylaxis. What complications should you try to prevent in patients on chronic corticosteroids?

. However, there is limited data on the subject largely because, despite much notoriety, there is limited data to even show that corticosteroids actually cause peptic ulcers in the first place. Initial reports of an association date as far back as 1951 [14]. Since then, a multitude of trials followed by meta-analyses have reviewed the topic. In 1976, a meta-analysis of over 3558 patients from 26 prospective, randomized, double-blind, placebo-controlled trials found no difference in [15]. Another meta (...) complications of corticosteroids. Lastly is the topic of PCP prophylaxis. While there are clear data and guidelines for patients with acquired immune deficiency syndrome (AIDS), the data is not as clear for other states of immunosuppresion. Although the first-line agent trimethoprim-sulfamethaxoazole (TMP-SMX) is very effective at preventing PCP, it comes with its own consequences including adverse drug reactions, cost, and risk of antibiotic resistance. As before, the risk of PCP is correlated with dose

2013 Clinical Correlations

153. Safety of topical corticosteroids in pregnancy. (PubMed)

Safety of topical corticosteroids in pregnancy. Topical corticosteroids are the most frequently prescribed dermatological treatment and are frequently used by pregnant women with skin conditions. However, little is known about their safety in pregnancy.To assess the effects of topical corticosteroids on pregnancy outcomes.On 5th May 2009 we searched the Cochrane Skin Group Specialised Register, the Cochrane Pregnancy and Childbirth Group Specialised Register, CENTRAL (The Cochrane Library 2009 (...) , Issue 2), MEDLINE (from 2003), and EMBASE (from 2005). We searched LILACS, CINAHL, British Nursing Index, SCI-EXPANDED, BIOSIS Previews, Conference Papers Index, and Conference Proceedings Citation Index-Science from inception to May 2009. We scanned the bibliographies of the included studies, published reviews, and articles that had cited the included studies. Pharmaceutical companies that have introduced an original topical corticosteroid product were contacted.Randomised controlled trials

2009 Cochrane

154. Spongiotic Trachyonychia Treated with Topical Corticosteroids Using the Paper Tape Occlusion Method (PubMed)

Spongiotic Trachyonychia Treated with Topical Corticosteroids Using the Paper Tape Occlusion Method 27843923 2018 11 13 2296-9195 2 1-2 2016 Sep Skin appendage disorders Skin Appendage Disord Spongiotic Trachyonychia Treated with Topical Corticosteroids Using the Paper Tape Occlusion Method. 49-51 Sakiyama Tomo T Department of Dermatology, Keio University School of Medicine, Tokyo, Japan. Chaya Ayaka A Department of Dermatology, Keio University School of Medicine, Tokyo, Japan. Shimizu Tomoko T (...) Department of Dermatology, Keio University School of Medicine, Tokyo, Japan. Ebihara Tamotsu T Department of Dermatology, Keio University School of Medicine, Tokyo, Japan. Saito Masataka M Department of Dermatology, Keio University School of Medicine, Tokyo, Japan. eng Editorial 2016 05 21 Switzerland Skin Appendage Disord 101670617 2296-9160 Nail matrix Paper tape occlusion method Spongiosis Topical corticosteroids Trachyonychia 2016 02 08 2016 04 22 2016 11 16 6 0 2016 11 16 6 0 2016 11 16 6 1 ppublish

Full Text available with Trip Pro

2016 Skin appendage disorders

155. Topical steroids better than vitamin D for treating scalp psoriasis

. In extreme cases it can cause hair loss, although this is usually only temporary. Topical treatments (creams and ointments for the skin) such as corticosteroids (steroids) and vitamin D are usually the first treatments tried, but applying them to the scalp is difficult because of hair on the head. It is also not clear which works best. This study aimed to help doctors and patients decide which of the wide variety of topical treatments available work best, and the type and frequency of any side effects (...) treatments were made: topical steroid alone versus vitamin D alone; combination therapy (corticosteroid and vitamin D therapy) versus steroid alone; combination therapy versus vitamin D alone. Trials concerning these three outcomes were rated as moderate or high quality, most lasted less than six months, and around half were carried out or sponsored by the manufacturer of the study medication. Sponsor involvement can bias results – in this case they can be more likely to find differences where

2018 NIHR Dissemination Centre

156. Insect Bites - Guidelines for Prescribing Topical Hydrocortisone

that topically applied vinegar to neutralize wasp stings will be effective as the venom spreads deep into tissues within a few minutes. Prescription drug option Hydrocortisone 1% cream, lotion or ointment is indicated for topical therapy where anti-inflammatory, anti-allergic and anti-pruritic activity is required. Hydrocortisone 1% is considered a mild corticosteroid. Note: Hydrocortisone 1% is Schedule 1 (Rx) only for patients under 2. Otherwise, it is an OTC product that is not eligible for the minor (...) are more cosmetically acceptable and work best for inflammatory lesions. Topical hydrocortisone should not be applied to tubercular, bacterial or fungal infections of the skin, or to certain viral skin eruptions such as herpes simplex and chickenpox ,or to reactions at vaccination injection sites. Use with caution in patients with skin diseases associated with impaired circulation and in patients receiving other immunosuppressants. Pregnancy : The use of topical corticosteroids is generally considered

2016 medSask

157. Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis (PubMed)

Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis Patients suffering from allergic rhinitis often attempt to self-manage their symptoms and may seek advice from pharmacists about nonprescription product choices. Several drug classes, both prescription and over-the-counter (OTC), are available, including intranasal corticosteroids (INCSs); oral, intranasal, and ocular antihistamines; leukotriene antagonists; and topical and systemic

Full Text available with Trip Pro

2017 Integrated pharmacy research & practice

158. Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray and ANTI-ANGIN® FORMULA, Topical Metered Spray in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx, Accompanied b

Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray and ANTI-ANGIN® FORMULA, Topical Metered Spray in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx, Accompanied b Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray and ANTI-ANGIN® FORMULA, Topical Metered Spray in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx (...) , Accompanied by a Sore Throat - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray and ANTI-ANGIN® FORMULA, Topical Metered Spray

2017 Clinical Trials

159. Intra-articular and soft tissue injections, a systematic review of relative efficacy of various corticosteroids

injections, a systematic review of relative efficacy of various corticosteroids. Clinical Rheumatology 2014: epub PubMedID DOI Indexing Status Subject indexing assigned by NLM MeSH Adrenal Cortex Hormones /administration & Animals; Betamethasone /administration & Clinical Trials as Topic; Humans; Injections, Intra-Articular /methods; Joint Diseases /drug therapy; Methylprednisolone /administration & Osteoarthritis, Knee /drug therapy; Tendinopathy /drug therapy; Triamcinolone Acetonide /administration (...) Intra-articular and soft tissue injections, a systematic review of relative efficacy of various corticosteroids Intra-articular and soft tissue injections, a systematic review of relative efficacy of various corticosteroids Intra-articular and soft tissue injections, a systematic review of relative efficacy of various corticosteroids Garg N, Perry L, Deodhar A CRD summary This review concluded that there was insufficient evidence on the comparative efficacy of different corticosteroid

2014 DARE.

160. Corticosteroid-eluting bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis

via small openings (ostia). Rhinosinusitis occurs when the mucosal lining of the paranasal sinuses becomes inflamed and infected. Typical symptoms include fever, pain and tenderness over the infected area, together with a blocked or runny nose. Acute rhinosinusitis frequently resolves spontaneously with little or no treatment, but it can become chronic. 2.2 The symptoms of chronic rhinosinusitis are usually managed with analgesics, antibiotics, topical corticosteroids or nasal irrigation (...) . Foam dressings, nasal packing and middle meatal spacers are sometimes used after surgery to try to maintain sinus patency. 3 3 The procedure The procedure 3.1 Inserting a corticosteroid-eluting bioabsorbable stent or spacer for paranasal sinus disease aims to deliver topical corticosteroid after surgery and to maintain patency of the newly created drainage system. It is usually done with the patient under general anaesthesia, during functional endoscopic sinus surgery, which may include balloon

2016 National Institute for Health and Clinical Excellence - Interventional Procedures

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>